Gadoxetate Disodium
CAS No. 135326-22-6
Gadoxetate Disodium ( Gd-EOB-DTPA Disodium,ZK 139834 )
Catalog No. M22181 CAS No. 135326-22-6
Gadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 33 | In Stock |
|
5MG | 53 | In Stock |
|
10MG | 87 | In Stock |
|
25MG | 161 | In Stock |
|
50MG | 286 | In Stock |
|
100MG | 426 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGadoxetate Disodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionGadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging.
-
DescriptionGadoxetate Disodium is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging. It is a contrast agent in magnetic resonance imaging (MRI) of the hepatobiliary system. It accumulates in normal, functioning hepatocytes.
-
SynonymsGd-EOB-DTPA Disodium,ZK 139834
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers
-
IndicationTransient Severe Arterial Phase Motion
Chemical Information
-
CAS Number135326-22-6
-
Formula Weight725.71
-
Molecular FormulaC23H28GdN3Na2O11
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[Na+].[Na+].[Gd+3].CCOc1ccc(CC(CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)N(CC([O-])=O)CC([O-])=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Schuhmann-Giampieri G, et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology. 1992 Apr;183(1):59-64.
molnova catalog
related products
-
Benzylpropyl acetate
The tubers of Lepidium meyenii Walp.
-
Irosustat
Irosustat is a potent steroid sulfatase inhibitor, with an IC50 of 8 nM, and exhibits anti-breast cancer activity.
-
Linderalactone
Linderalactone showed significant inhibitory effects on superoxide anion generation by human neutrophils in response to fMLP/CB, values of IC5 is 8.48 μg/mL.